July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Development of Portable Pupillometer for Assessment of Optic Nerve Disease.
Author Affiliations & Notes
  • Megha Bindiganavale
    Opthalmology, Stanford University, Palo Alto, California, United States
  • Heather Moss
    Opthalmology, Stanford University, Palo Alto, California, United States
  • Footnotes
    Commercial Relationships   Megha Bindiganavale, None; Heather Moss, None
  • Footnotes
    Support  Funding from NIH K23 024345, Research to Prevent Blindness Unrestricted Grant to Stanford Department of Ophthalmology, NIH P30 EY 026877
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3605. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Megha Bindiganavale, Heather Moss; Development of Portable Pupillometer for Assessment of Optic Nerve Disease.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3605.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Our goal is to configure and validate the use of a portable device to perform quantitative pupillometry. A portable pupillometer might be useful in the clinic and in the research setting for diagnosis and monitoring of optic neuropathies and neurological disease.

Methods : Light stimulation and pupil recording protocols were implemented using the retEVAL device (LKC Technologies Inc) using the Lua programming language following those used by Park et al (IOVS 2011) including manipulation of duration and intensity of blue light flashes. Full protocols were completed in 1 eye of 2 control subjects. In addition response to a 1-sec bright blue (316.2 cd/m2) flash following 3 minutes of dark adaptation was recorded in both eyes of two subjects with unilateral chronic optic neuropathies with clinically detectable relative afferent pupillary defects on clinical exam. Maximum pupillary constriction (1s after stimulus onset) and the post-illumination pupillary response (6-8s after stimulus onset) were extracted.

Results : For control subjects the pupil response curves for different intensities and duration of blue light stimuli were similar to those reported by Park et al. Following 1s flashes of 316 cd/m2 blue light maximum constriction was 53%, 55% in control subjects, 26.9%, 29.3% in affected eyes and 37.9%, 52.23% in unaffected eyes and PIPR were 19.5%, 36.3% in the control subjects, 17%, 8.6% in the affected eyes and 19%, 16% in the unaffected eyes.

Conclusions : The portable pupilometer measured maximum constriction to a 1s bright blue stimulus to be reduced in eyes with optic neuropathy compared with fellow eyes and control subject eyes. This provides initial validation for our portable pupilometer. Additional studies are needed to establish the normal range of responses and the clinical role in diagnosis and monitoring.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Control vs. Patient: Pupil Response to 1s Bright Blue Flash

Control vs. Patient: Pupil Response to 1s Bright Blue Flash

 

Pupil Response to Variable Intensity 1s Blue Flashes

Pupil Response to Variable Intensity 1s Blue Flashes

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×